United Therapeutics (UTHR) Return on Invested Capital (2017 - 2025)

United Therapeutics (UTHR) has 7 years of Return on Invested Capital data on file, last reported at 0.03% in Q4 2025.

• For the quarter ending Q4 2025, Return on Invested Capital rose 3.0% year-over-year to 0.03%; the trailing twelve-month figure through Dec 2025 stood at 0.03% (up 3.0% YoY), and the FY2024 full-year result was 0.03%, changed N/A from the prior year.
• Return on Invested Capital advanced to 0.03% in Q4 2025, from 0.02% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q4 2025 to a low of 0.01% in Q3 2024.
• A 3-year average of 0.01% and a median of 0.01% in 2025 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital fell 1 bps in 2024 and advanced 3 bps in 2025, its largest moves.
• Tracing UTHR's Return on Invested Capital over 3 years: stood at 0.02% in 2023, then slumped by 62 bps to 0.01% in 2024, then surged by 381 bps to 0.03% in 2025.
• Business Quant data shows UTHR's Return on Invested Capital at 0.03% in Q4 2025, 0.02% in Q3 2025, and 0.01% in Q2 2025.